Linked Life Data

7712335

Source:http://linkedlifedata.com/resource/pubmed/id/7712335

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1995-5-12
pubmed:abstractText
Major new developments in the understanding of the molecular mechanisms involved in immune recognition of self, and immune mediated rejection of foreign antigens, have resulted in the development of a variety of novel therapeutic strategies for the treatment of cancer. Cornerstones of the advances in this area have been the identification of tumour antigens and demonstration of immune recognition of neoplastic cells, most notably in malignant melanoma. There are now a number of clinical immune gene therapy trials in progress for the treatment of cancer by stimulating immune mediated rejection of malignant cells. Here we examine the evidence for immune recognition of ovarian tumour cells and the presence of putative ovarian tumour antigens as potential targets for immune gene therapy of ovarian carcinoma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0969-7128
pubmed:author
pubmed:issnType
Print
pubmed:volume
2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7-15
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Ovarian tumour antigens as potential targets for immune gene therapy.
pubmed:affiliation
Department of Molecular Medicine, King's College School of Medicine and Dentistry, Denmark Hill, London, UK.
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't